However, analysis of TGCA database data revealed that AIF-1 mRNA expression was significantly lower in lung adenocarcinoma and lung SCC than in normal tissue irrespective of p53 mutation status, disease stage or nodal stage (P < 0.001 vs. normal tissue; Fig 1A). This evidence concerns the gene TP53 and lung adenocarcinoma.